| Literature DB >> 27649123 |
Jun Li1, Qiang Xu2, Hua Jiang3.
Abstract
Saikosaponin (SS) A is a compound with various pharmacological properties and is easily degraded into SS-B1 and SS-G under acid conditions. In the present work, two new degradation products of SS-A, formed under acid hydrolytic conditions, were detected and isolated using analytical and semi-preparative liquid chromatography technology; furthermore, their structures were characterized as hydroxy-saikosaponin A and SS-B2 by spectral analysis, which is not only essential in stability-indicating method development and validation, but also could be used as a worst case scenario to assess the analytical method performance of SS-A. Moreover, their structural transformation pathways are also proposed.Entities:
Keywords: acid hydrolysis; degradation product; saikosaponin A
Mesh:
Substances:
Year: 2016 PMID: 27649123 PMCID: PMC6274035 DOI: 10.3390/molecules21091232
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structural formula of SS-A.
Figure 2HPLC chromatography of SS-A (2) and its acid degradation products (1, 3, 4, 5) under the detection wavelengths of 210 nm (pink line) and 254 nm (black line).
Degradation products of saikosaponin A formed in acid-forced degradation experiments.
| No. | Peak Label | Retention Time (min) | Peak Information |
|---|---|---|---|
| 1 | Peak-1 | 4.50 | Unknown impurity |
| 2 | Peak-2 | 11.50 | Saikosaponin A |
| 3 | Peak-3 | 14.75 | Unknown impurity |
| 4 | Peak-4 | 16.00 | Saikosaponin G |
| 5 | Peak-5 | 21.50 | Saikosaponin B1 |
13C-NMR spectral data comparison of Peak 1 with SS-B3 and Peak 3 with SS-B1 (C5D5N, δppm).
| No. | Peak1 | SS-B3 | Peak3 | SS-B1 | No. | Peak1 | SS-B3 | Peak3 | SS-B1 |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 41.5 | 40.1 | 38.4 | 38.4 | 23 | 64.3 | 64.2 | 64.7 | 64.0 |
| 2 | 26.8 | 26.5 | 26.1 | 26.1 | 24 | 13.7 | 13.6 | 13.1 | 13.1 |
| 3 | 81.8 | 81.7 | 81.6 | 81.5 | 25 | 18.3 | 18.2 | 18.4 | 18.9 |
| 4 | 43.9 | 43.9 | 43.8 | 43.7 | 26 | 18.3 | 18.5 | 17.4 | 17.0 |
| 5 | 47.8 | 47.6 | 47.3 | 47.3 | 27 | 26.8 | 26.5 | 21.8 | 22.0 |
| 6 | 17.8 | 17.9 | 18.9 | 18.2 | 28 | 68.7 | 68.5 | 64.7 | 64.0 |
| 7 | 33.3 | 33.3 | 32.5 | 32.6 | 29 | 33.5 | 33.3 | 25.1 | 24.9 |
| 8 | 41.0 | 41.0 | 41.2 | 40.5 | 30 | 24.0 | 24.0 | 32.3 | 32.4 |
| 9 | 55.7 | 54.0 | 54.0 | 54.5 | CH3O | 52.1 | |||
| 10 | 36.9 | 36.8 | 36.7 | 36.5 | 1′ | 106.1 | 106.0 | 106.0 | 106.0 |
| 11 | 66.8 | 75.9 | 126.3 | 127.0 | 2′ | 71.6 | 71.8 | 71.8 | 71.7 |
| 12 | 128.1 | 122.5 | 126.3 | 125.7 | 3′ | 85.2 | 85.3 | 85.5 | 85.4 |
| 13 | 145.2 | 148.3 | 136.2 | 136.4 | 4′ | 71.9 | 71.9 | 71.9 | 71.7 |
| 14 | 43.9 | 43.9 | 42.0 | 44.2 | 5′ | 71.1 | 71.0 | 71.1 | 71.1 |
| 15 | 38.2 | 37.0 | 32.6 | 35.0 | 6′ | 17.4 | 17.2 | 17.2 | 17.2 |
| 16 | 66.4 | 66.2 | 67.9 | 76.5 | 1′′ | 106.8 | 106.7 | 106.7 | 106.7 |
| 17 | 43.9 | 44.0 | 45.4 | 44.4 | 2′′ | 75.9 | 75.9 | 75.9 | 75.8 |
| 18 | 43.9 | 44.0 | 133.1 | 133.3 | 3′′ | 78.9 | 78.8 | 78.7 | 78.8 |
| 19 | 46.5 | 47.0 | 39.1 | 38.4 | 4′′ | 72.2 | 72.2 | 72.2 | 72.2 |
| 20 | 31.0 | 31.1 | 32.7 | 32.6 | 5′′ | 78.5 | 78.5 | 78.5 | 78.8 |
| 21 | 34.2 | 34.2 | 35.6 | 35.1 | 6′′ | 62.8 | 62.7 | 62.9 | 62.7 |
| 22 | 26.0 | 26.2 | 24.6 | 30.0 |
Figure 3Structural formulas of hydroxy-saikosaponin A (A); SS-B3 (B); SS-B1 (C); and SS-B2 (D).
Figure 4Proposed structural transformation pathway of hydroxy-saikosaponin A.
Figure 5Proposed structural transformation pathway of saikosaponin B2.
Figure 6Structural transformation map of saikosaponin A under the stress of acid hydrolytic conditions.